Immunological memory to SARS‐CoV‐2 infection and COVID‐19 vaccines

A Sette, S Crotty - Immunological reviews, 2022 - Wiley Online Library
Immunological memory is the basis of protective immunity provided by vaccines and
previous infections. Immunological memory can develop from multiple branches of the …

COVID-19 vaccination: The road ahead

DM Altmann, RJ Boyton - Science, 2022 - science.org
A diverse array of successful, first-generation SARS-CoV-2 vaccines have played a huge
role in efforts to bring the COVID-19 pandemic under control, even though inequitable …

[HTML][HTML] SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron

A Tarke, CH Coelho, Z Zhang, JM Dan, ED Yu… - Cell, 2022 - cell.com
We address whether T cell responses induced by different vaccine platforms (mRNA-1273,
BNT162b2, Ad26. COV2. S, and NVX-CoV2373) cross-recognize early SARS-CoV-2 …

Germinal centre-driven maturation of B cell response to mRNA vaccination

W Kim, JQ Zhou, SC Horvath, AJ Schmitz, AJ Sturtz… - Nature, 2022 - nature.com
Germinal centres (GC) are lymphoid structures in which B cells acquire affinity-enhancing
somatic hypermutations (SHM), with surviving clones differentiating into memory B cells …

SARS-CoV-2 Omicron-neutralizing memory B cells are elicited by two doses of BNT162b2 mRNA vaccine

R Kotaki, Y Adachi, S Moriyama, T Onodera… - Science …, 2022 - science.org
Multiple SARS-CoV-2 variants have mutations in the spike receptor binding domain (RBD)
with potential to evade neutralizing antibody. In particular, the Beta and Omicron variants …

BA. 2 and BA. 5 omicron differ immunologically from both BA. 1 omicron and pre-omicron variants

A Rössler, A Netzl, L Knabl, H Schäfer, SH Wilks… - Nature …, 2022 - nature.com
Several studies have shown that SARS-CoV-2 BA. 1 omicron is an immune escape variant.
Meanwhile, however, omicron BA. 2 and BA. 5 became dominant in many countries and …

COVID-19 vaccine booster: to boost or not to boost

R Shekhar, I Garg, S Pal, S Kottewar… - Infectious disease …, 2021 - mdpi.com
Developing safe and effective vaccines against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) at a breakneck speed has been an exceptional human …

Antibody and B cell responses to SARS-CoV-2 infection and vaccination: the end of the beginning

K Röltgen, SD Boyd - Annual Review of Pathology: Mechanisms …, 2024 - annualreviews.org
As the COVID-19 pandemic has evolved during the past years, interactions between human
immune systems, rapidly mutating and selected SARS-CoV-2 viral variants, and effective …

SARS-CoV-2 variants of concern and variants of interest receptor binding domain mutations and virus infectivity

H Liu, P Wei, JW Kappler, P Marrack… - Frontiers in …, 2022 - frontiersin.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has lasted
more than 2 years with over 260 million infections and 5 million deaths worldwide as of …

Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination

A Sokal, P Bastard, P Chappert… - Journal of Experimental …, 2022 - rupress.org
Inborn and acquired deficits of type I interferon (IFN) immunity predispose to life-threatening
COVID-19 pneumonia. We longitudinally profiled the B cell response to mRNA vaccination …